Cross Country Healthcare - CCRN Stock Forecast, Price & News

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cross Country Healthcare in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CCRN shares.
View CCRN analyst ratings or view top-rated stocks.

5 Wall Street analysts have issued 12 month price targets for Cross Country Healthcare's stock. Their CCRN share price forecasts range from $26.00 to $42.00. On average, they anticipate the company's stock price to reach $34.20 in the next twelve months. This suggests a possible upside of 11.0% from the stock's current price.
View analysts price targets for CCRN or view top-rated stocks among Wall Street analysts.

Cross Country Healthcare's stock was trading at $27.76 at the beginning of the year. Since then, CCRN shares have increased by 11.0% and is now trading at $30.80.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our CCRN earnings forecast.

Cross Country Healthcare, Inc. (NASDAQ:CCRN) released its quarterly earnings data on Wednesday, August, 3rd. The business services provider reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.35 by $0.05. The business services provider had revenue of $753.56 million for the quarter, compared to analysts' expectations of $741.57 million. Cross Country Healthcare had a net margin of 8.44% and a trailing twelve-month return on equity of 60.23%.

Cross Country Healthcare issued an update on its third quarter 2022 earnings guidance on Wednesday, October, 5th. The company provided earnings per share (EPS) guidance of $0.90-$1.00 for the period, compared to the consensus earnings per share estimate of $0.91. The company issued revenue guidance of $615.00 million-$625.00 million, compared to the consensus revenue estimate of $610.51 million.

39 employees have rated Cross Country Healthcare Chief Executive Officer John Martins on Glassdoor.com. John Martins has an approval rating of 73% among the company's employees. 86.0% of employees surveyed would recommend working at Cross Country Healthcare to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cross Country Healthcare investors own include NVIDIA (NVDA), Energy Transfer (ET), OPKO Health (OPK), Enphase Energy (ENPH), Overstock.com (OSTK), QUALCOMM (QCOM), Vista Outdoor (VSTO), Twilio (TWLO), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

Cross Country Healthcare trades on the NASDAQ under the ticker symbol "CCRN."

Shares of CCRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CCRN stock can currently be purchased for approximately $30.80.

Cross Country Healthcare (NASDAQ:CCRN) has a market capitalization of $1.18 billion and generates $1.68 billion in revenue each year. The business services provider earns $132 million in net income (profit) each year or $5.72 on an earnings per share basis.

The company employs 8,679 workers across the globe.

Cross Country Healthcare's mailing address is 5201 CONGRESS AVENUE SUITE 100B, BOCA RATON FL, 33487. The official website for the company is www.crosscountryhealthcare.com. The business services provider can be reached via phone at (561) 998-2232, via email at ir@crosscountry.com, or via fax at 302-636-5454.